MSDC-0602K

MSDC-0602K · Cirius Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for MSDC-0602K, covering 2020-08-21 to 2021-07-12. Get the full timeline:

Most recent: Clinical Trial Update: A Study of MSDC-0602K to Assess Glycemic Control and Cardiovascular Outcomes in Patients With Pre-T2D or T2D and NAFLD/NASH [Phase 3]

See pricing